These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9148918)

  • 1. A novel phosphotyrosine motif with a critical amino acid at position -2 for the SH2 domain-mediated activation of the tyrosine phosphatase SHP-1.
    Burshtyn DN; Yang W; Yi T; Long EO
    J Biol Chem; 1997 May; 272(20):13066-72. PubMed ID: 9148918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SHP-1 binds and negatively modulates the c-Kit receptor by interaction with tyrosine 569 in the c-Kit juxtamembrane domain.
    Kozlowski M; Larose L; Lee F; Le DM; Rottapel R; Siminovitch KA
    Mol Cell Biol; 1998 Apr; 18(4):2089-99. PubMed ID: 9528781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels.
    Lorenz U
    Immunol Rev; 2009 Mar; 228(1):342-59. PubMed ID: 19290938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biased suppression of hematopoiesis and multiple developmental defects in chimeric mice containing Shp-2 mutant cells.
    Qu CK; Yu WM; Azzarelli B; Cooper S; Broxmeyer HE; Feng GS
    Mol Cell Biol; 1998 Oct; 18(10):6075-82. PubMed ID: 9742124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of the cellular import of functionally active SH2-domain-interacting phosphopeptides.
    Kertész A; Váradi G; Tóth GK; Fajka-Boja R; Monostori E; Sármay G
    Cell Mol Life Sci; 2006 Nov; 63(22):2682-93. PubMed ID: 17075693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining SH2 domain and PTP specificity by screening combinatorial peptide libraries.
    Wavreille AS; Garaud M; Zhang Y; Pei D
    Methods; 2007 Jul; 42(3):207-19. PubMed ID: 17532507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A missense methionine mutation augments catalytic activity but reduces thermal stability in two protein tyrosine phosphatases.
    Bishop AC
    Biochem Biophys Res Commun; 2016 Dec; 481(1-2):153-158. PubMed ID: 27816449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The structural insights of stem cell factor receptor (c-Kit) interaction with tyrosine phosphatase-2 (Shp-2): an in silico analysis.
    Pati S; Gurudutta GU; Kalra OP; Mukhopadhyay A
    BMC Res Notes; 2010 Jan; 3():14. PubMed ID: 20205869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Comprehensive Immunoreceptor Phosphotyrosine-based Signaling Network Revealed by Reciprocal Protein-Peptide Array Screening.
    Liu H; Li L; Voss C; Wang F; Liu J; Li SS
    Mol Cell Proteomics; 2015 Jul; 14(7):1846-58. PubMed ID: 25907764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein tyrosine phosphatase SHP-2: a proto-oncogene product that promotes Ras activation.
    Matozaki T; Murata Y; Saito Y; Okazawa H; Ohnishi H
    Cancer Sci; 2009 Oct; 100(10):1786-93. PubMed ID: 19622105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consideration of SHP-1 as a Molecular Target for Tumor Therapy.
    Lim S; Lee KW; Kim JY; Kim KD
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-guided studies of the SHP-1/JAK1 interaction provide new insights into phosphatase catalytic domain substrate recognition.
    Alicea-Velázquez NL; Jakoncic J; Boggon TJ
    J Struct Biol; 2013 Mar; 181(3):243-51. PubMed ID: 23296072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and NMR studies of cyclic peptides targeting the N-terminal domain of the protein tyrosine phosphatase YopH.
    Leone M; Barile E; Dahl R; Pellecchia M
    Chem Biol Drug Des; 2011 Jan; 77(1):12-9. PubMed ID: 21118379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory receptors abound?
    Cambier JC
    Proc Natl Acad Sci U S A; 1997 Jun; 94(12):5993-5. PubMed ID: 9177155
    [No Abstract]   [Full Text] [Related]  

  • 15. Suppressing the killer instinct.
    Campbell KS
    Sci Signal; 2016 May; 9(429):fs8. PubMed ID: 27221707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CoDIAC: A comprehensive approach for interaction analysis reveals novel insights into SH2 domain function and regulation.
    Kandoor A; Martinez G; Hitchcock JM; Angel S; Campbell L; Rizvi S; Naegle KM
    bioRxiv; 2024 Jul; ():. PubMed ID: 39091881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-Wide Search for Tyrosine Phosphatases in the Human Genome Through Computational Approaches Leads to the Discovery of Few New Domain Architectures.
    Bhattacharyya T; Sowdhamini R
    Evol Bioinform Online; 2019; 15():1176934319840289. PubMed ID: 31007525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in synthetic and medicinal chemistry of phosphotyrosine and phosphonate-based phosphotyrosine analogues.
    Makukhin N; Ciulli A
    RSC Med Chem; 2020 Oct; 12(1):8-23. PubMed ID: 34041480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual-inhibitory domain iCARs improve the efficiency of the AND-NOT gate CAR T strategy.
    Bangayan NJ; Wang L; Burton Sojo G; Noguchi M; Cheng D; Ta L; Gunn D; Mao Z; Liu S; Yin Q; Riedinger M; Li K; Wu AM; Stoyanova T; Witte ON
    Proc Natl Acad Sci U S A; 2023 Nov; 120(47):e2312374120. PubMed ID: 37963244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diverse roles of C-type lectin-like receptors in immunity.
    Scur M; Parsons BD; Dey S; Makrigiannis AP
    Front Immunol; 2023; 14():1126043. PubMed ID: 36923398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.